The term ‘DH lymphoma’ was initially used to describe mature-B-cell lymphomas with a chromosomal breakpoint affecting the MYC locus in combination with another recurrent breakpoint, such as BCL2, BCL6, BCL3 or CCND1. The gene discussed is BCL2; the disease is B-cell non-Hodgkin lymphoma.